Abénex and Cisbio's management sold their direct and indirect stake in Cisbio Bioassays to PerkinElmer. As a result of these transactions, PerkinElmer owns 100% of Cisbio Bioassays. Financial terms were not disclosed. Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe. The addition of Cisbio’s capabilities to PerkinElmer will enable life science researchers to have access to assay tools that address the broad diversity of target types and biological configurations, for both small molecule and biologic drug discovery.